BIMATOPROST/TIMOLOL TEVA 0.3 mg/ml + 5 mg/ml, eye drop solution bottle, 3 ml
Active ingredients: Bimatoprost, Timolol maleate, TIMOLOL
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 3 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BIMATOPROST/TIMOLOL TEVA 0,3 mg/mL + 5 mg/mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon compte-gouttes polyéthylène basse densité (PEBD) avec fermeture de sécurité de 3 mL
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jun 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63759509CIP73010761CIP133400930107614Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MALÉATE DE TIMOLOLcollyre | — | SA |
| TIMOLOLcollyre | 5 mg · 1 mL de solution | FT |
| BIMATOPROSTcollyre | 0,3 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.